{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:47:42Z","timestamp":1792176462025,"version":"4.4.0"},"reference-count":17,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"published-print":{"date-parts":[[1989,4,1]]},"DOI":"10.1136\/jnnp.52.4.472","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T21:16:40Z","timestamp":1226351800000},"page":"472-476","source":"Crossref","is-referenced-by-count":99,"title":["Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia."],"prefix":"10.1136","volume":"52","author":[{"given":"J M","family":"Zakrzewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P N","family":"Patsalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0404.1970.tb05803.x","article-title":"Facial pain treated with carbamazepine (Tegretol)","volume":"46","author":"Rassmusen, P.; Rushede, J.","year":"1970","unstructured":"Rassmusen P, Rushede J. Facial pain treated with carbamazepine (Tegretol). Acta Neurol Scand 1970; 46:385-408.","journal-title":"Acta Neurol Scand"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1966.00470140019003","article-title":"Controlled sequential trials of carbamazepine in trigeminal neuralgia","volume":"15","author":"Rockliff, B.W.; Davies, E.H.","year":"1966","unstructured":"Rockliff BW, Davies EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15: 129-36.","journal-title":"Arch Neurol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0091-6749(88)90059-0","article-title":"In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11 -epoxide and oxcarbazepine in the diagnosis of drug induced hypersensitivity","volume":"82","author":"Zakrzewska, J.M.; Ivanyi, L.","year":"1988","unstructured":"Zakrzewska JM, Ivanyi L. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10, 11 -epoxide and oxcarbazepine in the diagnosis of drug induced hypersensitivity. J Allergy Clin Immun 1988;82:110-5.","journal-title":"J Allergy Clin Immun"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/pgmj.57.663.16","article-title":"Long term treatment of trigeminal neuralgia with carbamazepine","volume":"57","author":"Taylor, J.C.; Brauer, S.; Espir, M.L.E.","year":"1981","unstructured":"Taylor JC, Brauer S, Espir MLE. Long term treatment of trigeminal neuralgia with carbamazepine. Postgrad Med J 1981;57:16-8.","journal-title":"Postgrad Med J"},{"key":"ref_5","article-title":"Clinical trial for the estimation of anticonvulsant properties and side reactions of a new drug ketocarbamazepine","volume-title":"Advances in Epileptology: Xth Epilepsy International Symposium","author":"Rai, P.V.","unstructured":"Rai PV. Clinical trial for the estimation of anticonvulsant properties and side reactions of a new drug ketocarbamazepine. In: Wada JA, Penry JK, eds. Advances in Epileptology: Xth Epilepsy International Symposium. New York: Raven Press, 1980:357."},{"key":"ref_6","first-page":"297","article-title":"Oxcarbazepine in the treatment of epilepsy-a usable alternative to carbamazepine?","volume":"155","author":"Philbert, A.; Dam, M.; Jackobsen, K.","year":"1986","unstructured":"Philbert A, Dam M, Jackobsen K. Oxcarbazepine in the treatment of epilepsy-a usable alternative to carbamazepine? Irish J Med Sci 1986;155:297.","journal-title":"Irish J Med Sci"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0920-1211(87)90003-9","article-title":"Comparison of oxcarbazepine and carbamazepine: a double blind study","volume":"1","author":"Reinikainen, K.J.; Keranen, T.; Halonen, T.; Komulainen, H.; Riekkinen, P.J.","year":"1987","unstructured":"Reinikainen KJ, Keranen T, Halonen T, Komulainen H, Riekkinen PJ. Comparison of oxcarbazepine and carbamazepine: a double blind study. Epilepsy Res 1987;1:284-9.","journal-title":"Epilepsy Res"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00498258609043567","article-title":"The metabolism of '4C-oxcarbazepine in man","volume":"16","author":"Schutz, H.; Feldman, K.F.; Faigle, J.W.; Kriemler, H.P.; Winkler, T.","year":"1986","unstructured":"Schutz H, Feldman KF, Faigle JW, Kriemler HP, Winkler T. The metabolism of '4C-oxcarbazepine in man. Xenobiotica 1986;16:769-78.","journal-title":"Xenobiotica"},{"key":"ref_9","first-page":"545","article-title":"Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers","volume":"22","author":"Theisohn, M.; Heimann, G.","year":"1982","unstructured":"Theisohn M, Heimann G. Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers. Eur J Pharmacol 1982;22:545-51.","journal-title":"Eur J Pharmacol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-0327(85)90022-9","article-title":"The use of sodium valporate, carbamazepine and oxcarbazepine in patients with affective disorders","volume":"8","author":"Emrich, H.M.; Dose, M.; von Zerssen, D.","year":"1985","unstructured":"Emrich HM, Dose M, von Zerssen D. The use of sodium valporate, carbamazepine and oxcarbazepine in patients with affective disorders. J Affective Disord 1985;8:243-50.","journal-title":"J Affective Disord"},{"key":"ref_11","first-page":"676","article-title":"GP 4779 and spasticity","volume":"i:","author":"Bittencourt, P.R.; Oxcarbazepine, Silvado C.E.","year":"1985","unstructured":"Bittencourt PR, Silvado CE. Oxcarbazepine, GP 4779 and spasticity. Lancet 1985;i:676.","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000116315","article-title":"Trigeminal neuralgia: its treatment with two new carbamazepine analogues","volume":"26","author":"Farago, F.","year":"1987","unstructured":"Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 1987;26: 73-83.","journal-title":"Eur Neurol"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"Hospital anxiety and depression scale","volume":"67","author":"Zigmond, A.S.; Snaith, R.P.","year":"1983","unstructured":"Zigmond AS, Snaith RP. Hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.","journal-title":"Acta Psychiatr Scand"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/archneur.1980.00500600047009","article-title":"Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration","volume":"37","author":"Tomson, T.; Tybring, G.; Bertilsson, L.; Ekbon, K.; Rane, A.","year":"1980","unstructured":"Tomson T, Tybring G, Bertilsson L, Ekbon K, Rane A. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch Neurol 1980;37:699-703.","journal-title":"Arch Neurol"},{"key":"ref_15","article-title":"A microanalytical high pressure liquid chromatographic technique for the assay of oxcarbazepine and its primary metabolite 10OH-carbazepine","author":"Elyas, A.A.; Goldberg, V.D.; Patsalos, P.N.","year":"1988","unstructured":"Elyas AA, Goldberg VD, Patsalos PN. A microanalytical high pressure liquid chromatographic technique for the assay of oxcarbazepine and its primary metabolite 10OH-carbazepine. J Chromatogr 1988; (in press).","journal-title":"J Chromatogr"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1528-1157.1987.tb03702.x","article-title":"Oxcarbamazepine (GP 47.680): a possible alternative to carbamazepine","volume":"28","author":"Houtkooper, M.A.; Lammertsma, A.; Meyer, J.W.A.; Goedhart, D.M.; Meinardi, H.; van Oorschot, C.E.A.H.; Blom, G.F.; Hoppener, R.J.E.A.; Hulsman, J.A.R.J.","year":"1987","unstructured":"Houtkooper MA, Lammertsma A, Meyer JWA, Goedhart DM, Meinardi H, van Oorschot CEAH, Blom GF, Hoppener RJEA, Hulsman JARJ. Oxcarbamazepine (GP 47.680): a possible alternative to carbamazepine. Epilepsia 1987;28:693-8.","journal-title":"Epilepsia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0920-1211(87)90025-8","article-title":"Hyponatremia induced by oxcarbazepine","volume":"1","author":"Johannessen, A.C.; Nielsen, O.A.","year":"1987","unstructured":"Johannessen AC, Nielsen OA. Hyponatremia induced by oxcarbazepine. Epilepsy Res 1987;1: 155-6.","journal-title":"Epilepsy Res"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp.52.4.472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:26:42Z","timestamp":1601094402000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp.52.4.472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,4,1]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/jnnp.52.4.472","relation":{},"ISSN":["0022-3050"],"issn-type":[{"value":"0022-3050","type":"print"}],"subject":[],"published":{"date-parts":[[1989,4,1]]}}}